Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Trail receptors, nucleic acids encoding the same, and methods of use thereof

a technology of nucleic acids and receptors, applied in the field of trail receptors and nucleic acids encoding the same, can solve the problem of unclear physiological control mechanisms that regulate this form of programmed cell death

Inactive Publication Date: 2002-08-22
THOMAS JEFFERSON UNIV
View PDF1 Cites 31 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it is unclear what physiological control mechanisms regulate this form of programmed cell death or how the cell death pathways interact with other physiological processes within the organism.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Trail receptors, nucleic acids encoding the same, and methods of use thereof
  • Trail receptors, nucleic acids encoding the same, and methods of use thereof
  • Trail receptors, nucleic acids encoding the same, and methods of use thereof

Examples

Experimental program
Comparison scheme
Effect test

examples

[0139] Unless otherwise stated, the present invention was performed using standard procedures, as described, for example in Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., USA (1982); Sambrook et al., Molecular Cloning: A Laboratory Manual (2 ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., USA (1989); Davis et al., Basic Methods in Molecular Biology, Elsevier Science Publishing, Inc., New York, USA (1986); or Methods in Enzymology: Guide to Molecular Cloning Techniques Vol 152, S. L. Berger and A. R. Kimmerl Eds., Academic Press Inc., San Diego, USA (1987).

example i

Cloning and Characterization of DR5 and TRAIL-R3

[0140] This example demonstrates the identification and cloning of DR5 and TRAIL-R3 cDNA. Briefly, several EST clones were identified and their 3' and 5' sequences were compiled. Based on the compiled sequences, PCR primers were generated and used to clone two cDNAs which encode two novel members of the TRAIL-receptor family (FIGS. 1A and 1B).

[0141] To identify novel members of the TNF-receptor family, an approach combining information from the GenBank database of human expressed sequence tags (ESTs) and PCR was employed (see Alnemri E. S. et al. (1996) Proc. Natl. Sci. USA. 93, 7464-7469; Fernandez-Alnemri et al., Cancer Res. 5S:2737-2742 (1995); and Fernandez-Alnemri et al., Cancer Res. 55:6045-6052 (1995)). Initially, a search of the GenBank EST data base for sequences related to TRAIL receptor-1, also referred to as "DR4", identified several EST clones, which were used to derive 5' and 3' PCR primers to clone related cDNAs.

[0142] T...

example ii

Expression Analyst. of DR5 and TRAIL-R3 mRNA

[0150] This example demonstrates the mRNA expression patterns of DR5 and TRAIL-R3 in normal and tumor cells.

[0151] FIG. 1D shows a Northern blot analysis of the expression of DR5 (upper panels) and TRAIL-R3 (lower panels) mRNAs in normal tissues and tumor cell lines. X-ray film exposure time in the two lower panels and the upper left panel was for 48 hours, whereas in the upper right panel was for 2 hours. The cell lines assayed were: HL-60, promyelocytic leukemia; HeLa cell S3, K-562, chronic myelogenous leukemia; MOLT-4, lymphoblastic leukemia; Raji, Burkitt's lymphoma; SW480, colorectal adenocarcinoma; A549, lung carcinoma; G361, melanoma. Numbers on the right in FIG. 1D indicate kilobases.

[0152] Northern blot analysis of equivalent amounts of mRNA samples from normal human tissues and tumor cell lines, with a DR5 riboprobe, detected a .about.4 kb transcript in all the samples (FIG. 1D, upper panels). Surprisingly, the amount of DR5 tra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

In accordance with the present invention, there are provided isolated mammalian TRAIL receptor proteins, antibodies thereto, therapeutic compositions, and nucleic acids encoding such. Bioassays and therapeutic methods employing invention DR5 and TRAIL-R3 proteins are also provided.

Description

[0001] This application claims priority from United States provisional application serial No. 60 / 055,906, filed Aug. 15, 1997, now abandoned.BACKGROUND INFORMATION[0003] Apoptosis is a normal physiological process of cell death that plays a critical role in the regulation of tissue homeostasis by ensuring that the rate of new cell accumulation produced by cell division is offset by a commensurate rate of cell loss due to death. It has now become clear that disturbances in apoptosis, also referred to as physiological cell death or programmed cell death, that prevent or delay normal cell turnover can be just as important to the pathogenesis of diseases as are known abnormalities in the regulation of proliferation and the cell cycle. Like cell division, which is controlled through complex interactions between cell cycle regulatory proteins, apoptosis is similarly regulated under normal circumstances by the interaction of gene products that either induce or inhibit cell death.[0004] The...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A01K67/027C07K14/715C07K16/28C12N1/15C12N1/19C12N1/21C12N5/10C12N15/09C12N15/12C12P21/08C12Q1/68G01N33/15G01N33/50G01N33/53G01N33/566
CPCA01K2217/05C07K14/7151
Inventor ALNEMRI, EMAD S.
Owner THOMAS JEFFERSON UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com